Want to see JP:4263 full AI Analyst Report?
SUSMED,Inc. (4263) AI Stock Analysis
SUSMED,Inc.
(TSE/TYO:4263)
The overall score is heavily constrained by severe technical weakness and a lack of profitability. The primary support comes from the company's strong, debt-free balance sheet, which provides a financial cushion. However, the combination of a persistent downtrend, negative cash flows, and an unprofitable valuation creates a high-risk profile.
SUSMED,Inc. (4263) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.60B
- Dividend Yield
- ―
- Average Volume (3M)
- 144.70K
- Price to Earnings (P/E)
- -14.6
- Beta (1Y)
- 1.02
- Revenue Growth
- 7.39%
- EPS Growth
- -27.77%
- Country
- Japan
- Employees
- 50
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
SUSMED,Inc. Business Overview & Revenue Model
Company Description
SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast...
SUSMED,Inc. Financial Statement Overview
Summary
Strong revenue growth (+80.6%) and a debt-free balance sheet are offset by persistent net losses and significant negative cash flow. The high gross margin is promising, but the lack of profitability and cash burn weigh heavily on the score.
Income Statement
45NeutralBalance Sheet
85Very PositiveCash Flow
30Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 497.21M | 497.21M | 462.99M | 342.58M | 316.87M | 530.65M |
| Gross Profit | 479.82M | 479.82M | 450.72M | 330.85M | 306.50M | 522.67M |
| EBITDA | -306.47M | -319.99M | -289.22M | -350.22M | -231.11M | -43.99M |
| Net Income | -382.69M | -382.69M | -298.40M | -357.42M | -233.48M | -50.75M |
Balance Sheet | ||||||
| Total Assets | 4.22B | 4.22B | 4.50B | 4.93B | 4.94B | 5.10B |
| Cash, Cash Equivalents and Short-Term Investments | 3.70B | 3.70B | 4.40B | 4.85B | 4.90B | 5.05B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 147.94M | 147.94M | 132.33M | 327.79M | 93.34M | 230.33M |
| Stockholders Equity | 4.07B | 4.07B | 4.37B | 4.60B | 4.85B | 4.87B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -548.50M | -436.79M | -240.04M | -177.90M | 82.40M |
| Operating Cash Flow | 0 | -474.45M | -432.48M | -230.76M | -165.28M | 100.59M |
| Investing Cash Flow | 0 | -228.13M | -19.97M | -8.53M | -20.36M | -18.19M |
| Financing Cash Flow | 0 | 2.75M | 3.67M | 37.37M | 3.46B | 62.36M |
SUSMED,Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4263, the sentiment is Negative. The current price of 322.00 is below the 20-day moving average (MA) of 373.45, below the 50-day MA of 425.80, and below the 200-day MA of 755.77, indicating a bearish trend. The MACD of -28.31 indicates Positive momentum. The RSI at 18.48 is Positive, neither overbought nor oversold. The STOCH value of 9.34 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4263.
SUSMED,Inc. Peers Comparison
Overall Rating
JP:241378.5Outperform
JP:448372Outperform
JP:448063Neutral
JP:443850Neutral- JP:426346Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:2413 | 79Outperform | JPY 1.25T | 26.80 | 11.45% | 1.20% | 15.76% | 13.53% |
| JP:4483 | 72Outperform | JPY 241.50B | 34.84 | ― | 0.49% | 18.89% | 11.66% |
| JP:4480 | 63Neutral | JPY 75.89B | 39.69 | 12.35% | ― | 24.03% | 34.50% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4438 | 50Neutral | JPY 2.36B | -4.42 | ― | ― | 14.84% | 30.67% |
| JP:4263 | 46Neutral | JPY 5.63B | -14.62 | ― | ― | 7.39% | -27.77% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4263 | SUSMED,Inc. | 322.00 | -615.00 | -65.64% | |
| JP:2413 | M3 | 1820.00 | -322.59 | -15.06% | |
| JP:4480 | Medley, Inc. | 2323.00 | 191.00 | 8.96% | |
| JP:4438 | Welby Inc. | 282.00 | -7.00 | -2.42% | |
| JP:4483 | JMDC Inc. | 3540.00 | -1326.33 | -27.26% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 28, 2026